Livagen Bioregulatory Peptide
79 Inquiries
195875-84-4
Research Grade
99%
Hongkong
20mg*10vials/box
2026-10-11
PEPTIDES
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceTesofensine ((1R, 2R, 3S, 5S)-3-(3, 4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane)) is an inhibitor of neuronal reuptake of dopamine, noradrenaline, and serotonin. Tesofensine was developed for the treatment of Alzheimer's and Parkinson's disease but lacked efficacy. Meta-analysis revealed that tesofensine (0.125–1.0 mg, once daily; oral) produced dose-dependent weight loss, and 32% of obese patients had ≥ 5% weight loss following 14 wk of treatment. Weight loss was accompanied by hypophagia, suggesting an appetite suppressant action[2].
Tesofensine is a dopamine, serotonin, and noradrenaline (triple) reuptake inhibitor originally developed by NeuroSearch for the treatment of Alzheimer's disease and Parkinson's disease. Development of the compound for these neurological indications was unsuccessful but significant weight loss was reported during the clinical trials in Parkinson's disease. Hence, tesofensine is now being developed by NeuroSearch for the treatment of obesity and type 2 diabetes[1].Research & Reference NoteLivagen Bioregulatory Peptide is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Basic Info-
Product Name:
tesofensine
Other Name:(1S,3S,4R,5R)-3-(3,4-dichlorophenyl)-4-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane;(1R,2R,3S,5S)-3-(3,4-Dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane;Tesofensine-13C-d3;8-Azabicyclo[3.2.1]octane, 3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-, (1R,2R,3S,5S)-;Tesofensine 500mcg Tablets;Tesofensine 0.5mg Tablets
CAS No.:195875-84-4
Molecular Formula:C17H23Cl2NO
InChIKeys:VCVWXKKWDOJNIT-ZOMKSWQUSA-N
Molecular Weight:328.28
Exact Mass:328.28
UNII:BLH9UKX9V1
Color/Form:White to off-white
Categories:
Characteristics-
Density:
1.161±0.06 g/cm3(Predicted)
Boiling Point:396.6±42.0 °C(Predicted)
PKA:10.46±0.60(Predicted)
Critical Temperature & Pressure:Store at -20°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
PEPTIDES
-
Location:
Room 305, 3rd Floor, Unit 2, Building 48, Datangxia Zone 2, Choucheng Subdistrict, Yiwu, Jinhua, Zhejiang Province, China
-
Year of Establishment:
2026
-
-
Inquiry History79 Inquiries
Country Product Purchase Quantity Date Posted
United Kingdom
CAS: 195875-84-4
10 G Oct 25, 2025
Indonesia
High quality Tesofensine 500mcg cas 195875-84-4 100pcs/bottle
4 Apr 18, 2025
United States
High Purity Tesofensine Powder 99% White Powder CAS 195875-84-4 EGC-Tesofensine Powder
1 KG Oct 27, 2023
United States
Tesofensine
15 G Aug 20, 2026
United Kingdom
tesofensine
1 G Apr 20, 2026
United States
Tesofensine
1 MT Apr 19, 2026
United Kingdom
Tesofensine
100 PCS Apr 13, 2026
New Zealand
Tesofensine
10 MG Mar 14, 2026
United States
Tesofensine
100 G Feb 28, 2026
United States
Tesofensine
1 MT Feb 26, 2026
United States
Tesofensine
500 Feb 24, 2026
United States
Tesofensine
1 G Feb 20, 2026
United States
Tesofensine
10 G Jan 28, 2026
United States
Tesofensine
1 G Jan 27, 2026
United States
Tesofensine
10 G Dec 6, 2025
Lithuania
Tesofensine
100 MT Nov 10, 2025
France
Tesofensine
200 PCS Nov 10, 2025
United Kingdom
Tesofensine
1 G Oct 26, 2025
United Kingdom
Tesofensine
200 G Oct 14, 2025
United States
Tesofensine 500 mch tablets or capsules only
1 PCS Sep 23, 2025 Post an enquiry for this product